Lineage Cell Therapeutics Inc Revenue per Employee (LCTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lineage Cell Therapeutics Inc   (NYSE: LCTX)
 

Lineage Cell Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Lineage Cell Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 169,909, below the company average number of $83,854.
Within the Healthcare sector Employees of 402 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 3061, from total ranking in previous quarter at 3610. Lineage Cell Therapeutics Inc has 77 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LCTX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -61.34 % 14.85 % 130.4 % -2.59 % 96.38 %
Sales per Employee (TTM) $ 169,909 191,935 189,039 140,468 141,740
LCTX's Total Ranking # 3061 # 3610 # 3309 # 3323 # 3413
Seq. Revenue Change -38.03 % -73.9 % 79.52 % 33.13 % 84.09 %

LCTX Company Profile >> Back to LCTX Efficiency Comparisons >> Compare LCTX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 49
Healthcare Sector # 403
Overall Market # 3061

Revenue per Employee Statistics
High Average Low
$ 191,935 $ 83,854 $ 22,117
(Mar 31 2026)   (Mar 31 2021)



Financial Statements
Lineage Cell Therapeutics Inc 's Revenue MRQ $ 1 Millions Visit LCTX's Income Statement
Lineage Cell Therapeutics Inc 's Revenues TTM $ 13 Millions Visit LCTX's aggregate revenue growth
What are LCTX's Sales? Visit LCTX's Sales by Segment




Other Ratios
Lineage Cell Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LCTX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LCTX's Competitors
Revenue per Employee for LCTX's Suppliers
Revenue per Employee for LCTX's Customers

You may also want to know
LCTX's Sales Growth Rates LCTX's Pe Price to earnings ratio LCTX's Receivables Turnover Ratio LCTX's Stock Quote
LCTX's Net Income Growth Rates LCTX's Ps Price to Sales ratio LCTX's Sales per Employee LCTX's Asset Turnover Ratio
LCTX's Net Margin LCTX's Pb Price to Book ratio LCTX's Financial Strength Ratios LCTX's Dividend Payout Ratio
Date modified: 2026-09-08T18:37:39+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Kura Oncology Inc   297,019.23 $ 77.225  Million 260 
Adapthealth Corp   296,028.35 $ 3,226.709  Million 10,900 
Pulmonx Corporation  295,246.62 $ 87.393  Million 296 
Enovis Corp  294,147.40 $ 2,294.938  Million 7,802 
Cytek Biosciences Inc   292,145.30 $ 205.086  Million 702 
Becton Dickinson And Company  289,444.44 $ 20,840.000  Million 72,000 
International Stem Cell Corporation  288,303.03 $ 9.514  Million 33 
Radnet Inc   288,228.15 $ 2,268.932  Million 7,872 
Beta Bionics Inc   284,554.76 $ 119.513  Million 420 
Vaso Corporation  284,468.09 $ 80.220  Million 282 
Prelude Therapeutics Inc  283,848.10 $ 22.424  Million 79 
Apyx Medical Corp  283,439.02 $ 58.105  Million 205 
Cytosorbents Corporation  276,455.52 $ 35.663  Million 129 
Cv Sciences Inc   274,227.27 $ 12.066  Million 44 
Cvrx inc   269,793.72 $ 60.164  Million 223 
Lifeward ltd   269,407.41 $ 21.822  Million 81 
Personalis Inc   267,957.69 $ 69.669  Million 260 
Cytomx Therapeutics Inc   265,246.38 $ 18.302  Million 69 
Revvity Inc  264,710.09 $ 2,911.811  Million 11,000 
Arcturus Therapeutics Holdings Inc   264,576.58 $ 29.368  Million 111 
Innovative Eyewear Inc   262,462.92 $ 3.412  Million 13 
Surrozen Inc   261,613.64 $ 11.511  Million 44 
Dentsply Sirona Inc   260,214.29 $ 3,643.000  Million 14,000 
Harvard Bioscience Inc   260,070.80 $ 88.164  Million 339 
Opko Health Inc   258,415.82 $ 587.896  Million 2,275 
Vycor Medical Inc   258,210.43 $ 1.807  Million 7 
Ardent Health Inc   254,203.97 $ 6,405.940  Million 25,200 
Rosecliff Acquisition Corp I  253,338.46 $ 16.467  Million 65 
Cryoport inc   252,644.99 $ 186.452  Million 738 
Zai Lab Limited  252,025.78 $ 449.614  Million 1,784 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.